Edwards Lifesciences Corporation (BVMF:E1WL34)

Edwards Lifesciences Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	257,698	272,484	270,051	224,398	243,862	450,653
Market Cap Growth	-0.10%	0.90%	20.34%	-7.98%	-45.89%	52.62%
Enterprise Value	239,595	255,146	247,284	219,045	238,302	444,465
Last Close Price	110.77	118.80	115.20	93.06	98.90	183.13
PE Ratio	43.58	46.08	10.46	32.98	30.31	53.81
PS Ratio	7.71	8.15	8.03	9.23	10.33	15.46
PB Ratio	4.53	4.79	4.34	6.88	7.94	13.86
P/TBV Ratio	6.29	6.65	6.20	9.06	10.59	18.62
P/FCF Ratio	35.05	37.06	150.61	71.94	47.38	57.51
P/OCF Ratio	29.33	31.01	80.51	51.63	37.87	46.70
EV/Sales Ratio	7.70	7.63	7.35	9.01	10.10	15.25
EV/EBITDA Ratio	25.60	25.81	24.62	28.05	26.81	46.34
EV/EBIT Ratio	28.51	28.28	27.00	30.35	29.24	50.28
EV/FCF Ratio	32.58	34.70	137.92	70.23	46.30	56.73
Debt / Equity Ratio	0.07	0.07	0.07	0.10	0.12	0.12
Debt / EBITDA Ratio	0.39	0.39	0.42	0.42	0.40	0.39
Debt / FCF Ratio	0.53	0.53	2.42	1.07	0.71	0.49
Net Debt / Equity Ratio	-0.34	-0.34	-0.33	-0.14	-0.09	-0.13
Net Debt / EBITDA Ratio	-1.97	-1.97	-2.02	-0.59	-0.31	-0.45
Net Debt / FCF Ratio	-2.64	-2.64	-11.32	-1.47	-0.54	-0.55
Asset Turnover	0.45	0.45	0.49	0.57	0.53	0.67
Inventory Turnover	1.21	1.21	1.12	1.10	0.90	1.63
Quick Ratio	2.83	2.83	3.13	2.06	1.87	2.07
Current Ratio	3.72	3.72	4.18	3.38	3.03	3.08
Return on Equity (ROE)	10.35%	10.35%	16.64%	19.48%	22.74%	28.88%
Return on Assets (ROA)	7.65%	7.65%	8.26%	10.53%	11.47%	12.60%
Return on Invested Capital (ROIC)	19.58%	19.98%	21.26%	23.92%	25.98%	31.39%
Return on Capital Employed (ROCE)	13.80%	13.80%	12.80%	18.20%	21.20%	21.20%
Earnings Yield	2.29%	2.17%	9.56%	3.03%	3.30%	1.86%
FCF Yield	2.85%	2.70%	0.66%	1.39%	2.11%	1.74%
Buyback Yield / Dilution	2.25%	2.25%	1.66%	2.37%	1.11%	0.11%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.